Human Respiratory Syncytial Virus: An Introduction
- 28 July 2016
- book chapter
- Published by Springer Nature
- Vol. 1442, 1-12
Abstract
Human respiratory syncytial virus (RSV) is understood to be a significant human pathogen in infants, young children, and the elderly and the immunocompromised. Over the last decade many important mechanisms contributing to RSV infection, replication, and disease pathogenesis have been revealed; however, there is still insufficient knowledge which has in part hampered vaccine development. Considerable information is accumulating regarding how RSV proteins modulate molecular signaling and immune responses to infection. Understanding how RSV interacts with its host is crucial to facilitate the development of safe and effective vaccines and therapeutic treatments. In this chapter, we provide a brief introduction into RSV replication, pathogenesis, and host immune response, and summarize the state of RSV vaccine and antiviral compounds in clinical stages of development. This chapter frames features of this book and the molecular methods used for understanding RSV interaction with the host.Keywords
This publication has 92 references indexed in Scilit:
- RSV Fusion: Time for a New ModelViruses, 2013
- Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c MicePLOS ONE, 2012
- Increased Genetic and Phenotypic Stability of a Promising Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate by Reverse GeneticsJournal of Virology, 2012
- The Human Respiratory Syncytial Virus Matrix Protein Is Required for Maturation of Viral FilamentsJournal of Virology, 2012
- RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral StrategyAntimicrobial Agents and Chemotherapy, 2009
- Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab′)2 components mediates reduced pulmonary inflammation in miceJournal of General Virology, 2009
- Human Respiratory Syncytial Virus Nonstructural Protein NS2 Antagonizes the Activation of Beta Interferon Transcription by Interacting with RIG-IJournal of Virology, 2009
- Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2Journal of Virology, 2009
- Positive Selection Results in Frequent Reversible Amino Acid Replacements in the G Protein Gene of Human Respiratory Syncytial VirusPLOS Pathogens, 2009
- Respiratory syncytial virus infection provokes airway remodelling in allergen‐exposed mice in absence of prior allergen sensitizationClinical & Experimental Allergy, 2008